Orbital Compressive Syndrome in Sickle Cell Disease
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Global HOPE Problem Case Conference session will take place on Tuesday, April 18, 2023 at 8:00 a.m. In-person attendance will be available at the Texas Children’s Hospital Global HOPE Conference Room, Abercrombie A.0170.02; and virtual attendance will be available through Zoom.
Activity Information
Needs Statement
This education series is targeted at pediatric hematology-oncology faculty, residents, fellows, medical officers, clinical officers, nurses, pharmacists, medical students, and other healthcare professionals in the Global HOPE network in Africa and Houston involved in the management of children with pediatric hematological malignancies. The series aims to increase knowledge of the learners regarding the clinical challenges and appropriate management strategies in patients with pediatric hematological malignancies in resource-constrained settings, and encourages learners to implement the recommendations and protocols for adapted treatment in clinical practice to enhance the quality of patient care and outcomes.
Educational Objectives
At the conclusion of the session, the participants should be able to:
- Recognize orbital compressive syndrome as a rare and genuine ophthalmic emergency in patients with sickle cell disease.
- Discuss the difficulties in diagnosing and treating this syndrome.
- Review the multi-disciplinary approach to its management.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
- Nuclear Medicine
- Pathology
- Pediatrics
- Radiology
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Apatsa Matatiyo, M.B.B.S.
Medical Officer
Kamuzu Central Hospital
Lilongwe, Malawi
Disclosure:
Nothing to disclose.
Activity Director
-
Nmazuo Ozuah, M.M.B.S.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Gladstone Airewele, M.B.B.S., M.P.H.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Anna Francis Magembe, M.B.Ch.B., M.Med.
Pediatric Hematology-Oncology Fellow
Muhimbili University of Health and Allied Sciences, Tanzania
Disclosure:
Nothing to disclose.
-
Parth Mehta, M.D., M.P.H.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Ruth Namazzi, M.D.
Pediatric Hematology and Oncology Physician
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Nmazuo Ozuah, M.M.B.S.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: